PharMerica (PMC) Tops Q3 EPS by 11c; Boosts FY11 EPS Outlook
Tweet
Share
E-mailGet Alerts PMC Hot Sheet
Join SI Premium – FREE
PharMerica (NYSE: PMC) reported Q3 EPS of $0.31, $0.11 better than the analyst estimate of $0.20. Revenue for the quarter came in at $518.7 million versus the consensus estimate of $522.98 million.
PharMerica sees FY2011 EPS of $1.01-$1.06, versus prior guidance of $0.85-$0.95 and the consensus of $0.93. PharMerica sees FY2011 revenue of $2.08-$2.09 billion, versus prior guidance of $2.08-$2.11 billion and the consensus of $2.11 billion.
PharMerica sees FY2011 EPS of $1.01-$1.06, versus prior guidance of $0.85-$0.95 and the consensus of $0.93. PharMerica sees FY2011 revenue of $2.08-$2.09 billion, versus prior guidance of $2.08-$2.11 billion and the consensus of $2.11 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
- IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance
- Signet Jewelers (SIG) Tops Q2 EPS by 47c, Misses on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
